ChemPartner PharmaTech Co Ltd (300149) — Strategic Asset Allocation Index
ChemPartner PharmaTech Co Ltd (300149) has a Strategic Asset Allocation Index of 44.1% as of June 2023. Strategic assets (PP&E of CN¥1.05 Billion plus long-term investments of CN¥-) total CN¥1.05 Billion, measured against net assets of CN¥2.37 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 300149 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
ChemPartner PharmaTech Co Ltd Strategic Asset Allocation Index (2007–2022)
This chart shows how ChemPartner PharmaTech Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of June 2023, the index stands at 44.1%, representing strategic assets of CN¥1.05 Billion against net assets of CN¥2.37 Billion CNY. See financial flexibility index of ChemPartner PharmaTech Co Ltd to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for ChemPartner PharmaTech Co Ltd (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for ChemPartner PharmaTech Co Ltd from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300149 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 40.8% | CN¥973.62 Million | CN¥973.62 Million | CN¥- | CN¥2.39 Billion | ▼ -35.2 pp |
| 2021 | 76.0% | CN¥1.51 Billion | CN¥1.51 Billion | CN¥- | CN¥1.99 Billion | ▲ +37.4 pp |
| 2020 | 38.6% | CN¥946.13 Million | CN¥946.13 Million | CN¥- | CN¥2.45 Billion | ▲ +10.4 pp |
| 2019 | 28.1% | CN¥648.19 Million | CN¥648.19 Million | CN¥- | CN¥2.30 Billion | ▲ +2.5 pp |
| 2018 | 25.6% | CN¥564.46 Million | CN¥564.46 Million | CN¥- | CN¥2.20 Billion | ▲ +6.8 pp |
| 2017 | 18.8% | CN¥156.78 Million | CN¥156.78 Million | CN¥- | CN¥835.45 Million | ▼ -1.0 pp |
| 2016 | 19.8% | CN¥152.06 Million | CN¥152.06 Million | CN¥- | CN¥769.93 Million | ▼ -2.4 pp |
| 2015 | 22.2% | CN¥160.60 Million | CN¥160.60 Million | CN¥- | CN¥723.81 Million | ▼ -11.0 pp |
| 2014 | 33.2% | CN¥231.33 Million | CN¥231.33 Million | CN¥- | CN¥696.53 Million | ▲ +1.2 pp |
| 2013 | 32.0% | CN¥214.27 Million | CN¥214.27 Million | CN¥- | CN¥670.29 Million | ▲ +7.9 pp |
| 2012 | 24.1% | CN¥154.21 Million | CN¥154.21 Million | CN¥- | CN¥640.90 Million | ▲ +11.4 pp |
| 2011 | 12.7% | CN¥77.63 Million | CN¥77.63 Million | CN¥- | CN¥611.46 Million | ▲ +1.8 pp |
| 2010 | 10.9% | CN¥62.02 Million | CN¥62.02 Million | CN¥- | CN¥571.30 Million | ▼ -41.5 pp |
| 2009 | 52.4% | CN¥53.02 Million | CN¥53.02 Million | CN¥- | CN¥101.26 Million | ▲ +3.9 pp |
| 2008 | 48.5% | CN¥28.30 Million | CN¥28.30 Million | CN¥- | CN¥58.36 Million | ▼ -21.0 pp |
| 2007 | 69.5% | CN¥16.85 Million | CN¥16.85 Million | CN¥- | CN¥24.25 Million | — |